Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

scientific article published on 14 February 2008

Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MRFMMM.2008.02.005
P698PubMed publication ID18358501
P5875ResearchGate publication ID5492888

P50authorYunfei YuanQ40548428
Shi-Mei ZhuangQ63647398
Hang SuQ80931286
P2093author name stringJing Zhao
Ying Zhang
Teng Xu
Fan Zhou
Yujuan Xiong
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)27-35
P577publication date2008-02-14
P1433published inMutation ResearchQ6943732
P1476titleLarge-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China
P478volume641

Reverse relations

cites work (P2860)
Q40707010"Testing your methyl": DNA methylation profiling of serum DNA of HCC patients.
Q36134242Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma
Q36092123Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis
Q38339878Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
Q38254776Effects of Mutations of 3 Amino Acids on Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Q36698843Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
Q28385295Environmental toxicants, epigenetics, and cancer
Q38692795Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises
Q63349138Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma
Q41700141Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study
Q35899166Genome-wide DNA methylation profiles in hepatocellular carcinoma.
Q35606904Hepatitis B virus infection and the risk of hepatocellular carcinoma
Q26851211Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development
Q42040454Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
Q37496567Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients
Q34450660Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
Q36945012Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma
Q37584718TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis
Q34152847Therapeutics Based on microRNA: A New Approach for Liver Cancer
Q41933719p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).

Search more.